Source: Business Wire
LONDON–(BUSINESS WIRE)– #Biotechnology–The global cancer biologics market is poised to grow by USD 40.38 billion during 2019-2023, progressing at a CAGR of over 11%.
Amgen gets mixed decision from Fed Circuit on generic Sensipar
Source: Reuters
A federal appeals court on Tuesday dealt mixed news to Amgen Inc in its effort to block competing versions of its drug Sensipar from hitting the market, saying at least one proposed generic version would infringe an Amgen patent but another proposed generic would not.
Ann Deren-Lewis Appointed as Clarify Medical’s Senior Vice President of Corporate Development
Source: Business Wire
SAN DIEGO–(BUSINESS WIRE)–Clarify Medical today announced the appointment of Ann Deren-Lewis as its Senior Vice President of Corporate Development, effective immediately. Ms. Deren-Lewis brings to Clarify Medical over 20 years of experience in the dermatology market, including leadership roles in marketing, sales, product development, medical affairs, and corporate development for companies such as ChromaDex, Merz, Stiefel Labs (GSK), Johnson and Johnson, Genentech, and Amgen. Most recently,
